Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $275.64 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hologic Sales and Service, LLC | $82.56 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $75.37 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $24.70 | 1 | $0 (2024) |
| Hologic, LLC | $24.52 | 1 | $0 (2022) |
| Cumberland Pharmaceuticals, Inc. | $20.71 | 1 | $0 (2023) |
| ADC Therapeutics America, Inc. | $20.16 | 1 | $0 (2023) |
| Amgen Inc. | $16.20 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $11.42 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.13 | 2 | Merck Sharp & Dohme LLC ($24.70) |
| 2023 | $156.46 | 5 | Hologic Sales and Service, LLC ($82.56) |
| 2022 | $24.52 | 1 | Hologic, LLC ($24.52) |
| 2020 | $11.42 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($11.42) |
| 2018 | $38.11 | 2 | AstraZeneca Pharmaceuticals LP ($21.91) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2023 | Hologic Sales and Service, LLC | BREVERA BREAST BIOPSY SYSTEM (Device) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: Breast and Skeletal Health | ||||||
| 11/03/2023 | Hologic Sales and Service, LLC | HORIZON A (Device) | Food and Beverage | In-kind items and services | $51.59 | General |
| Category: Breast and Skeletal Health | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Oncology | ||||||
| 05/24/2023 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $20.16 | General |
| 12/16/2022 | Hologic, LLC | BREVERA BREAST BIOPSY SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Breast and Skeletal Health | ||||||
| 02/20/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Oncology | ||||||
| 07/26/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Oncology | ||||||
| 03/22/2018 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,944 | 2,054 | $162,078 | $59,531 |
| 2022 | 10 | 2,098 | 2,189 | $165,755 | $65,475 |
| 2021 | 10 | 2,422 | 2,521 | $194,266 | $80,523 |
| 2020 | 10 | 2,451 | 2,567 | $198,341 | $84,064 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 443 | 443 | $31,896 | $15,311 | 48.0% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 439 | 439 | $25,462 | $12,129 | 47.6% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 368 | 427 | $24,766 | $7,764 | 31.3% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 238 | 250 | $23,500 | $7,492 | 31.9% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 214 | 253 | $19,228 | $5,635 | 29.3% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Facility | 2023 | 22 | 22 | $7,876 | $2,707 | 34.4% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 33 | 33 | $11,880 | $2,409 | 20.3% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 111 | 111 | $7,616 | $2,326 | 30.5% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2023 | 18 | 18 | $6,084 | $1,950 | 32.1% |
| 77067 | Screening mammography | Office | 2023 | 29 | 29 | $2,088 | $1,007 | 48.2% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 29 | 29 | $1,682 | $801.13 | 47.6% |
| 77067 | Screening mammography | Facility | 2022 | 612 | 612 | $44,452 | $21,580 | 48.5% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 612 | 612 | $35,496 | $17,312 | 48.8% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2022 | 313 | 359 | $20,822 | $6,619 | 31.8% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2022 | 190 | 198 | $19,005 | $5,581 | 29.4% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2022 | 192 | 225 | $17,544 | $5,422 | 30.9% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Facility | 2022 | 24 | 24 | $8,746 | $2,961 | 33.9% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2022 | 105 | 108 | $7,561 | $2,265 | 30.0% |
| 77049 | Mri scan of both breasts | Facility | 2022 | 26 | 26 | $7,082 | $2,018 | 28.5% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2022 | 13 | 13 | $4,475 | $1,571 | 35.1% |
| 76882 | Limited ultrasound scan of joint or other extremity structure lacking blood vessels | Facility | 2022 | 11 | 12 | $572.00 | $146.14 | 25.5% |
| 77067 | Screening mammography of both breasts | Facility | 2021 | 759 | 759 | $55,407 | $27,385 | 49.4% |
| 77063 | Screening digital tomography of both breasts | Facility | 2021 | 756 | 756 | $43,848 | $21,703 | 49.5% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2021 | 313 | 355 | $20,592 | $7,058 | 34.3% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2021 | 193 | 196 | $19,012 | $6,259 | 32.9% |
About Dr. Francie Masters, M.D
Dr. Francie Masters, M.D is a Diagnostic Radiology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114180445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francie Masters, M.D has received a total of $275.64 in payments from pharmaceutical and medical device companies, with $45.13 received in 2024. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($275.64).
As a Medicare-enrolled provider, Masters has provided services to 8,915 Medicare beneficiaries, totaling 9,331 services with total Medicare billing of $289,593. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Lexington, KY
- Active Since 07/07/2008
- Last Updated 03/31/2025
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1114180445
Products in Payments
- BREVERA BREAST BIOPSY SYSTEM (Device) $55.49
- TAGRISSO (Drug) $53.46
- HORIZON A (Device) $51.59
- KEYTRUDA (Biological) $24.70
- FASLODEX (Drug) $21.91
- SANCUSO (Drug) $20.71
- Kyprolis (Biological) $16.20
- Stivarga (Drug) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Lexington
Philipp Lang, Md, MD
Diagnostic Radiology — Payments: $1.3M
Curtis Given, Md, MD
Diagnostic Radiology — Payments: $443,981
Dr. Roberto Galuppo Monticelli, M.d, M.D
Diagnostic Radiology — Payments: $17,404
Dr. Kimberly Stigers, M.d, M.D
Diagnostic Radiology — Payments: $17,038
Dr. Stephen Hobbs, M.d, M.D
Diagnostic Radiology — Payments: $9,968
Dr. Margaret Szabunio, Md, MD
Diagnostic Radiology — Payments: $5,787